BIOHAVEN PHARMACTL HLDG CO L's ticker is BHVN and the CUSIP is G11196105. A total of 231 filers reported holding BIOHAVEN PHARMACTL HLDG CO L in Q2 2020. The put-call ratio across all filers is 0.22 and the average weighting 0.7%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2021 | $1,709,000 | -82.5% | 25,000 | -78.1% | 0.25% | -80.3% |
| Q4 2020 | $9,771,000 | +31.4% | 114,000 | -0.3% | 1.28% | -12.2% |
| Q3 2020 | $7,434,000 | -11.1% | 114,350 | 0.0% | 1.45% | -13.9% |
| Q2 2020 | $8,360,000 | -6.9% | 114,350 | -30.7% | 1.69% | -4.3% |
| Q4 2019 | $8,983,000 | +34.6% | 165,000 | +3.1% | 1.76% | -27.0% |
| Q3 2019 | $6,675,000 | +1.6% | 160,000 | +6.7% | 2.41% | +20.6% |
| Q2 2019 | $6,569,000 | – | 150,000 | – | 2.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Knoll Capital Management, LLC | 450,422 | $6,251,857 | 14.11% |
| Liontrust Investment Partners LLP | 134,659 | $7,478,961 | 0.13% |
| Birchview Capital, LP | 7,365 | $102 | 0.07% |
| FNY Investment Advisers, LLC | 250 | $3 | 0.00% |
| FNY Investment Advisers, LLC | 18 | $0 | 0.00% |
| FNY Investment Advisers, LLC | 56 | $0 | 0.00% |
| McElhenny Sheffield Capital Management, LLC | 31 | $430 | 0.00% |
| Blue Trust, Inc. | 65 | $10 | 0.00% |
| IFP Advisors, Inc | 1 | $1 | 0.00% |